FasL-over-expressing T lymphocytes as effector cells in anti-prostate cancer gene therapy

被引：0
|
作者：
Bielawski, JC
Fowler, DH
Medin, JA
机构：
[1] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada
[2] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA
[3] Ontario Canc Inst, Div Expt Therapeut, Toronto, ON M4X 1K9, Canada
来源：
MOLECULAR THERAPY | 2004年 / 9卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
950
引用
收藏
页码：S364 / S364
页数：1
相关论文
共 50 条
  • [1] Anti-prostate specific membrane antigen designer T cells for prostate cancer therapy
    Ma, QZ
    Safar, M
    Holmes, E
    Wang, YW
    Boynton, AL
    Junghans, RP
    PROSTATE, 2004, 61 (01): : 12 - 25
  • [2] Immune privilege and FasL: two ways to inactivate effector cytotoxic T lymphocytes by FasL-expressing cells
    Li, JH
    Rosen, D
    Sondel, P
    Berke, G
    IMMUNOLOGY, 2002, 105 (03) : 267 - 277
  • [3] Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells
    J C Symes
    C Siatskas
    D H Fowler
    J A Medin
    Cancer Gene Therapy, 2009, 16 : 439 - 452
  • [4] Retrovirally transduced murine T lymphocytes expressing FasL mediate effective killing of prostate cancer cells
    Symes, J. C.
    Siatskas, C.
    Fowler, D. H.
    Medin, J. A.
    CANCER GENE THERAPY, 2009, 16 (05) : 439 - 452
  • [5] Endogenous Galectin-1 in T Lymphocytes Regulates Anti-prostate Cancer Immunity
    Corapi, Enrique
    Carrizo, Gustavo
    Compagno, Daniel
    Laderach, Diego
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [6] Advanced Generation Anti-Prostate Specific Membrane Antigen Designer T Cells for Prostate Cancer Immunotherapy
    Ma, Qiangzhong
    Gomes, Erica M.
    Lo, Agnes Shuk-Yee
    Junghans, Richard P.
    PROSTATE, 2014, 74 (03): : 286 - 296
  • [7] Therapy of prostate and breast cancer using erb-B2 specific chimeric receptor expressing effector lymphocytes
    Eshhar, Z
    Friedmann-Morvinski, D
    Pinthus, JH
    Malina, V
    Waks, T
    FASEB JOURNAL, 2003, 17 (07): : C128 - C129
  • [8] DOD award: Phase I trial of anti-prostate cancer therapy via anti-PSMA designer T cell autografting
    Junghans, Richard P.
    Ma, Qiangzhong
    Lum, Lawrence
    Rathore, Ritesh
    Cohen, Steven I.
    Somasundar, Ponnandai
    CANCER RESEARCH, 2006, 66 (08)
  • [9] DOD award: Phase I trial of anti-prostate cancer therapy via anti-PSMA designer T cell autografting
    Junghans, RP
    Ma, Q
    Lum, L
    Rathore, R
    Cohen, SI
    Somasundar, P
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 31 - 31
  • [10] The modification of T lymphocytes for the gene therapy of cancer
    Gilham, DE
    O'Neill, A
    Hughes, C
    Guest, R
    Lehane, M
    Kirillova, N
    Hawkins, RE
    BRITISH JOURNAL OF CANCER, 2001, 85 : 97 - 97
12345